| Literature DB >> 23637924 |
Xiaozhen Mou1, Xinxin Lu, Jisha Jacob, Shulei Sun, Robert Heath.
Abstract
Cyanobacterial harmful blooms (CyanoHABs) that produce microcystins are appearing in an increasing number of freshwater ecosystems worldwide, damaging quality of water for use by human and aquatic life. Heterotrophic bacteria assemblages are thought to be important in transforming and detoxifying microcystins in natural environments. However, little is known about their taxonomic composition or pathways involved in the process. To address this knowledge gap, we compared the metagenomes of Lake Erie free-living bacterioplankton assemblages in laboratory microcosms amended with microcystins relative to unamended controls. A diverse array of bacterial phyla were responsive to elevated supply of microcystins, including Acidobacteria, Actinobacteria, Bacteroidetes, Planctomycetes, Proteobacteria of the alpha, beta, gamma, delta and epsilon subdivisions and Verrucomicrobia. At more detailed taxonomic levels, Methylophilales (mainly in genus Methylotenera) and Burkholderiales (mainly in genera Bordetella, Burkholderia, Cupriavidus, Polaromonas, Ralstonia, Polynucleobacter and Variovorax) of Betaproteobacteria were suggested to be more important in microcystin degradation than Sphingomonadales of Alphaproteobacteria. The latter taxa were previously thought to be major microcystin degraders. Homologs to known microcystin-degrading genes (mlr) were not overrepresented in microcystin-amended metagenomes, indicating that Lake Erie bacterioplankton might employ alternative genes and/or pathways in microcystin degradation. Genes for xenobiotic metabolism were overrepresented in microcystin-amended microcosms, suggesting they are important in bacterial degradation of microcystin, a phenomenon that has been identified previously only in eukaryotic systems.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23637924 PMCID: PMC3634838 DOI: 10.1371/journal.pone.0061890
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1MC-LR structure and potential degradation pathways in bacteria.
Steps of the known cleavage pathway are linked by solid arrows. Steps through xenobiotic metabolism are linked by dotted arrows. Overrepresented genes in the MC metagenomes are labeled with asterisks and bold fonts. Unknown genes are labeled with question marks. Triangle indicates the cleavage site of mlrA. Ala: alanine, Arg: arginine, Adda: 3-amino-9-methoxy-2, 6, 8-trimethyl-10-phenyldeca-4, 6-dienoic acid, Cys: cysteine, Glu: glutamic acid, GSH: glutathione, Leu: leucine, MeAsp: methylaspartic acid.
Figure 2Variation of MC-LR concentration and total bacterial cell number during microcosm incubation.
(A) Average MC-LR concentrations and standard deviations in the MC and FW-MC microcosms. (B) Average bacterial abundance and standard deviations in MC and CT microcosms. Shaded areas indicate periods of pre-incubation with inorganic N and P for establishing carbon-limited conditions in microcosms.
Figure 3Distribution of bacterial cells of high (HI) and low (LI) metabolic activities during microcosm incubation.
(A) Flow cytometric analysis of bacterial cell distribution in the MC and CT microcosms after 48 hours of incubation. (B) Average relative abundance of HI and LI cells in the MC and CT microcosms during the course of incubation. (C) Average numbers of HI and LI cells and standard deviations in the MC and CT microcosms during the course of incubation.
Figure 4Clustering pattern of bacterioplankton 16S rRNA gene contents based on T-RFLP analysis.
Cluster analysis of T-RFLP data for original water samples (Ori 1 and 2), samples at the end of inorganic nutrient pre-incubation (Pre-incub 1 and 2) and samples at the end of MC-LR incubation experiments in the microcystin amended (MC1–48 h and MC2–48 h) and control (CT1–48 h and CT2–48 h) microcosms.
Sequence annotation statistics for the MC and CT metagenomes.
| Parameter | MC-1 | MC-2 | CT-1 | CT-2 |
| Number of unique sequences | 251,154 | 201,543 | 164,026 | 198,712 |
| Average sequence length (bp) | 386 | 366 | 414 | 377 |
| Number (%) of total rRNA genes | 1000 (0.4%) | 771 (0.4%) | 381 (0.2%) | 359 (0.2%) |
| Number (%) of total predicted protein-coding genes | 182,25 (73%) | 140,86 (70%) | 83,621 (51%) | 91,778 (46%) |
| Number (%) of protein-coding genes categorized by COG groups | 121,80 (67%) | 92,719 (66%) | 53,754 (64%) | 61,742 (67%) |
| Number (%) of protein-coded genes categorized by KEGG pathways | 168,118 (92%) | 129,469 (92%) | 72,542 (87%) | 83,391 (91%) |
Figure 5Significantly overrepresented gene categories in the MC metagenomes, relative to those in the CT metagenomes.
(A) General COG categories. (B) General KEGG categories. Calculations were based on relative abundance of each gene categories between the MC and CT metagenomes. Significance overrepresentation was reported when OR>1, P<0.02.
Overrepresented COG groups in the MC metagenomes relative to the CT metagenomes, based on odds ratios (OR) calculated between the copy number of putative gene sequences in the MC and CT metagenomes.
| COG | COG description | Class | Class description | MC | CT | ORMC/CT |
|
| ||||||
| 0243* | Anaerobic dehydrogenases, typically selenocysteine-containing | C | Energy production and conversion | 361 | 97 | 2.0 |
| 5013* | Nitrate reductase alpha subunit | C | Energy production and conversion | 110 | 6 | 9.9 |
| 1362 | Aspartyl aminopeptidase | E | Amino acid transport and metabolism | 94 | 1 | 50.6 |
| 3696* | Putative silver efflux pump | P | Inorganic ion transport and metabolism | 938 | 254 | 2.0 |
|
| ||||||
| 0583* | Transcriptional regulator | K | Transcription | 888 | 182 | 2.6 |
|
| ||||||
| 1291 | Flagellar motor component | N | Cell motility | 128 | 10 | 6.9 |
| 0643 | Chemotaxis protein histidine kinase andrelated kinases | NT | Cell motility/Signal transduction mechanisms | 348 | 64 | 2.9 |
| 0840 | Methyl-accepting chemotaxis protein | NT | Cell motility/Signal transduction mechanisms | 442 | 43 | 5.5 |
| 2804 | Type II secretory pathway, ATPase PulE/Tfppilus assembly pathway, ATPase PilB | NU | Cell motility/Intracellular trafficking, secretion,and vesicular transport | 551 | 166 | 1.9 |
| 3419 | Tfp pilus assembly protein, tip-associatedadhesin PilY1 | NU | Cell motility/Intracellular trafficking, secretion,and vesicular transport | 113 | 11 | 5.5 |
| 5008 | Tfp pilus assembly protein, ATPase PilU | NU | Cell motility/Intracellular trafficking, secretion,and vesicular transport | 256 | 21 | 6.6 |
| 0625 | Glutathione S-transferase | O | Posttranslational modification, protein turnover, chaperones | 352 | 92 | 2.1 |
| 1391 | Glutamine synthetase adenylyltransferase | OT | Posttranslational modification, protein turnover, chaperones/Signal transduction mechanisms | 238 | 46 | 2.8 |
| 0642* | Signal transduction histidine kinase | T | Signal transduction mechanisms | 962 | 343 | 1.5 |
| 0664* | cAMP-binding proteins - catabolite geneactivator and regulatory subunit ofcAMP-dependent protein kinases | T | Signal transduction mechanisms | 367 | 95 | 2.1 |
| 0841 | Cation/multidrug efflux pump | V | Defense mechanisms | 1693 | 512 | 1.8 |
| 1566 | Multidrug resistance efflux pump | V | Defense mechanisms | 376 | 104 | 1.9 |
Only those COG groups that were discussed in the present study or have been reported previously (labeled with asterisks) are shown. A full list is provided in Table S3.
Significantly enriched KEGG pathways in the MC metagenomes relative to the CT metagenomes, based on odds ratios (OR) calculated between the copy number of putative gene sequences in the MC and CT metagenomes.
| KEGG Pathway | General Processes | Functional Description | MC | CT | ORMC/CT |
|
| |||||
| 2030 | Cell Motility | Bacterial chemotaxis | 2257 | 343 | 3.7 |
| 2040 | Cell Motility | Flagella assembly | 2458 | 518 | 2.7 |
|
| |||||
| 2020 | Signal Transduction | Two-component system | 8185 | 2297 | 2.1 |
| 3070 | Membrane Transport | Bacterial secretion system | 3063 | 1264 | 1.4 |
|
| |||||
| 0480 | Metabolism of Other Amino Acids | Glutathione metabolism | 2254 | 954 | 1.3 |
| 0540 | Glycan Biosynthesis and Metabolism | Lipopolysaccharide biosynthesis | 1822 | 539 | 1.9 |
| 0550 | Glycan Biosynthesis and Metabolism | Peptidoglycan biosynthesis | 2815 | 1279 | 1.2 |
| 0564 | Lipid Metabolism | Glycerophospholipid metabolism | 1542 | 613 | 1.4 |
| 0680 | Energy Metabolism | Methane metabolism | 3805 | 1807 | 1.2 |
| 0780 | Metabolism of Cofactors and Vitamins | Biotin metabolism | 469 | 136 | 1.9 |
| 0860 | Metabolism of Cofactors and Vitamins | Porphyrin and chlorophyll metabolism | 3160 | 1122 | 1.6 |
| 0910 | Energy Metabolism | Nitrogen metabolism | 2900 | 184 | 1.3 |
| 0920 | Energy Metabolism | Sulfur metabolism | 1379 | 535 | 1.4 |
| 0980 | Xenobiotics Biodegradation | Xenobiotics metabolism by Cytochrom P450 | 342 | 124 | 1.5 |
Figure 6Taxonomic distribution of COG sequences in the MC and CT metagenomes.
(A) At the order level. (B) At the family level. (C) At the genus level. Only major taxa are shown (collectively accounted for >4% of total metagenomic sequences). Asterisks are to label bacterial taxa with different relative abundance between the MC and CT metagenomes (OR >1, P<0.02).
Figure 7Percent distribution of major bacterial orders that were affiliated with GST and genes.